News
Effective Sept. 15, Marie-France Tschudin, president, innovative medicines international, chief commercial officer, will be leaving Novartis. In her place, the company has added Patrick Horber with ...
I wish her the very best as she pursues her next chapter.” “I look forward to welcoming Patrick to Novartis. He is a proven leader with deep experience enabling commercial performance on a ...
Additionally, Patrick Horber, SVP and president of immunology at AbbVie, will join Novartis as president, international. Horber spent more than 10 years at AbbVie, starting out as a GM in Switzerland ...
ZURICH, Sept 6 (Reuters) - Novartis (NOVN.S), opens new tab has appointed AbbVie (ABBV.N), opens new tab executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said ...
To replace her, Novartis has poached the head of immunology from the world’s top inflammatory disease drug maker, AbbVie. Patrick Horber, M.D., who just recently rose to lead AbbVie’s ...
Patrick Horber, M.D., currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year, reporting to Vas Narasimhan, M.D., ...
I wish her the very best as she pursues her next chapter." "I look forward to welcoming Patrick to Novartis. He is a proven leader with deep experience enabling commercial performance on a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results